Fedenia Advisers’s Boston Scientific BSX Stock Holding History

Fedenia Advisers’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$21K	Buy	+492	New	+$26.7K	0.01%	303
2025 Q4	–	Sell	-6,714	Closed	-$655K	–	159
2025 Q3	$655K	Buy	6,714 +401	+6%	+$41.5K	0.26%	82
2025 Q2	$678K	Buy	6,313 +254	+4%	+$25.7K	0.32%	72
2025 Q1	$611K	Buy	6,059 +5,129	+552%	+$516K	0.4%	46
2024 Q4	$83.1K	Buy	+930	New	+$81.9K	0.05%	227

Other funds holding BSX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

BPC

Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return

FFM

Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return

BPCE

Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return

Fedenia Advisers's BSX Position: Q2 2026 in Review

Fedenia Advisers opened a new position in Boston Scientific (BSX) in Q2 2026: 492 shares worth $21K. The stake represents 0.01% of the portfolio and ranks #303 among its holdings. This is a return to the name: Fedenia Advisers previously reported a position in BSX as recently as Q3 2025.

Fedenia Advisers first reported a position in BSX in Q4 2024 and has held it in 5 quarters since. The position peaked at $678K in Q2 2025. 338 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Fedenia Advisers held 492 shares of Boston Scientific worth $21K as of Q2 2026.
Boston Scientific was a new Fedenia Advisers position in Q2 2026.
Boston Scientific made up 0.01% of Fedenia Advisers's portfolio in Q2 2026, its #303 holding.
Fedenia Advisers first reported a position in Boston Scientific in Q4 2024 and has held it in 5 quarters since.
Fedenia Advisers's Boston Scientific position peaked at $678K in Q2 2025.
338 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Fedenia Advisers's 13F filing for Q2 2026, filed 22 Jul 2026.